murin
encephalomyel
viru
tmev
infect
wide
use
anim
model
studi
demyelin
disord
includ
multipl
sclerosi
ms
immunosuppress
cytokin
interleukin
il
counteract
hyperact
immun
respons
critic
control
immun
homeostasi
infecti
autoimmun
disord
order
investig
effect
signal
via
receptor
infecti
neurolog
diseas
tmevinfect
sjl
mice
treat
block
antibodi
ab
acut
chronic
phase
diseas
find
demonstr
abmedi
neutral
lead
progress
coliti
reduct
regulatori
cell
increas
number
memori
cell
well
activ
cell
uninfect
mice
ii
concurr
acut
tmevinfect
worsen
enter
diseasemedi
neutral
virustrigg
effect
associ
enhanc
activ
helper
cell
cytotox
lymphocyt
augment
cytokin
express
contrast
iii
neutral
chronic
tmevinfect
associ
enhanc
peripher
immunopatholog
increas
cell
influx
spinal
cord
neutral
caus
breakdown
peripher
immun
toler
genet
predispos
mice
lead
immunemedi
coliti
resembl
inflammatori
bowel
diseas
hyperact
immun
state
follow
blockad
enhanc
central
nervou
systemrestrict
viral
infect
diseas
phasedepend
manner
murin
encephalomyel
viru
tmev
infect
wide
use
anim
model
studi
demyelin
disord
includ
human
multipl
sclerosi
ms
follow
intracerebr
infect
genet
suscept
mous
strain
sjl
mice
develop
viral
persist
delayedtyp
hypersensit
myelinspecif
autoimmun
spinal
cord
myelin
loss
resembl
chronic
progress
ms
lesion
contrast
resist
mice
elimin
viru
central
nervou
system
cn
specif
cellular
immun
includ
effector
cytotox
lymphocyt
ctl
respons
acut
infect
phase
interleukin
il
antiinflammatori
cytokin
secret
varieti
cell
type
main
function
includ
downregul
proinflammatori
cytokin
express
reduct
antigen
ag
present
reduc
cell
activ
ligat
receptor
lead
phosphoryl
transloc
signal
transduc
activ
transcript
molecul
promot
transcript
suppressor
cytokin
signal
lead
profound
immun
inhibitori
effect
thu
counteract
hyperact
immun
respons
critic
control
immun
homeostasi
autoimmun
cn
disord
experiment
autoimmun
encephalomyel
eae
exert
protect
effect
reduc
cellmedi
tissu
damag
critic
role
immunemedi
disord
also
demonstr
human
inflammatori
bowel
diseas
ibd
chronic
relaps
idiopath
inflamm
intestin
tract
signal
defect
caus
particularli
earli
onset
ibd
lossoffunct
mutat
affect
contribut
develop
earlyonsetibd
seriou
enter
diseas
children
moreov
genet
defici
either
transgen
mice
lead
breakdown
immun
toler
immun
mediat
coliti
repres
wellestablish
murin
model
ibd
also
influenc
diseas
outcom
sever
persist
viral
infect
instanc
cytokin
contribut
cell
exhaust
persist
lymphocyt
choriomening
viru
lcmv
infect
mice
circumv
treatment
block
antibodi
ab
similarli
genet
abmedi
blockad
signal
decreas
mortal
rate
brain
viru
load
murin
west
nile
viru
wnv
infect
contrast
knockout
mice
infect
neurotrop
strain
mous
hepat
viru
exhibit
overwhelm
morbid
increas
mortal
without
affect
viru
clearanc
addit
produc
regulatori
cell
treg
allevi
acut
enceph
mous
hepat
virusinfect
mice
suggest
mechan
reduc
cn
immunopatholog
thu
contrast
primari
benefici
effect
autoimmun
disord
ambival
function
consid
infecti
cn
diseas
contribut
insuffici
protect
eg
antivir
immun
one
hand
limit
immunopatholog
refer
theiler
murin
encephalomyel
tme
enhanc
express
measur
brain
sjl
mice
nevertheless
function
relev
inhibitori
cytokin
effect
pharmacolog
modul
pathway
remain
larg
undetermin
ms
model
aim
present
studi
gain
insight
immun
regul
sjl
mice
prone
develop
varieti
immunemedi
disord
includ
tmevinduc
demyelin
order
determin
diseasephas
specif
effect
cn
infect
upon
system
immunopatholog
defici
induc
administr
cytokin
receptor
block
antibodi
acut
chronic
demyelin
tme
phase
respect
addit
potenti
impact
system
defici
upon
neuropatholog
infecti
ms
model
investig
result
illustr
abil
abmedi
neutral
caus
immun
enhanc
progress
coliti
sjl
mice
aggrav
concurr
tmevinfect
diseas
phasedepend
manner
fourweekold
femal
specif
pathogen
free
sjljcrhsd
mice
purchas
harlan
winkelmann
borchen
germani
group
hous
isol
ventil
cage
tecniplast
germani
dark
cycl
anim
free
access
tap
water
standard
rodent
diet
rmh
ssniff
gmbh
soest
germani
assign
randomli
three
experi
experi
examin
effect
blockad
acut
infecti
condit
onset
demyelin
anim
receiv
rat
antimous
antibodi
ab
tmevinfect
group
earli
tmev
b
immunoglobulin
specif
isotyp
control
tmevinfect
group
isotyp
earli
tmev
c
rat
antimous
ab
mockinfect
group
earli
mock
respect
comparison
experi
ii
includ
also
three
anim
group
group
late
tmev
isotyp
late
tmev
late
mock
ab
isotyp
control
administ
later
time
point
investig
blockad
chronic
tmevinfect
onset
demyelin
experi
iii
perform
investig
signal
effect
noninfecti
condit
consist
noninfect
sjl
mice
treat
ab
group
rat
isotyp
control
group
isotyp
day
antibodi
applic
describ
vivo
monoclon
antibodi
treatment
subgroup
includ
five
anim
studi
design
illustr
fig
experi
conduct
accord
german
law
anim
protect
european
commun
council
direct
protect
anim
use
experiment
purpos
approv
author
anim
experi
given
local
author
landesamt
verbraucherschutz
und
lebensmittelsicherheit
lave
oldenburg
germani
permiss
number
anim
experi
intraperiton
inject
rat
antimous
ab
group
earli
tmev
earli
mock
clone
bioxcel
west
lebanon
usa
blockad
rat
immunoglobulin
specif
isotyp
control
group
isotyp
earli
tmev
bioxcel
west
lebanon
usa
describ
anim
treat
weekli
dpi
experi
ii
ab
group
late
tmev
late
mock
isotyp
control
group
isotyp
late
tmev
administ
dpi
experi
iii
mice
receiv
ab
group
isotyp
control
group
isotyp
day
age
five
week
day
post
infect
dpi
anim
experi
ii
intracerebr
inocul
beanstrain
tmev
receiv
mockinfect
describ
previous
briefli
intracerebr
inocul
carri
gener
anesthesia
medetomidin
mgkg
im
domitor
pfizer
karlsruh
germani
ketamin
mg
kg
intraperiton
ip
ketamin
wdt
eg
garbsen
germani
plaqueform
unit
viru
resolv
modifi
medium
paa
laboratori
germani
fetal
calf
serum
gentamicin
sigmaaldrich
chemi
gmbh
taufkirchen
germani
inject
right
cerebr
hemispher
mockinfect
anim
receiv
vehicl
intracerebr
neg
control
second
group
receiv
isotyp
control
instead
ab
third
group
mockinfect
b
experi
ii
tmevinfect
anim
receiv
ab
weekli
dpi
grey
box
necropsi
perform
group
five
anim
dpi
neg
control
second
group
receiv
isotyp
control
instead
ab
third
group
mockinfect
c
experi
iii
anim
receiv
ab
weekli
day
grey
box
necropsi
perform
group
five
anim
day
first
ab
applic
neg
control
second
group
receiv
isotyp
control
instead
ab
experi
weekli
clinic
score
rotarod
perform
test
quantifi
motor
coordin
deficit
perform
two
examin
au
ab
nonblind
manner
previous
describ
briefli
anim
score
weekli
follow
clinic
paramet
gener
appear
normal
appear
mild
chang
shaggi
scruffi
hair
moder
chang
scruffi
appear
hunch
back
sever
chang
unkempt
appear
urinari
incontin
b
behavior
activ
chang
mild
chang
mildli
reduc
spontan
movement
moder
chang
moder
reduc
spontan
activ
unchang
induc
activ
sever
chang
spontan
movement
reduc
induc
activ
c
gait
normal
gait
mild
chang
mild
ataxia
inconsist
waddl
gait
moder
chang
moder
ataxia
consist
waddl
gait
sever
chang
sever
ataxia
reduc
right
respons
spastic
paresi
hind
leg
final
score
point
calcul
summar
score
aforement
paramet
anim
reach
maximum
point
one
multipl
paramet
exclud
experi
euthan
immedi
anim
welfar
purpos
rotarod
perform
test
quantif
motor
coordin
conduct
acceler
rod
tse
system
gmbh
bad
homburg
v
germani
five
round
per
minut
rpm
rpm
maximum
period
five
minut
rpm
valu
automat
record
mice
fell
rod
three
measur
per
anim
perform
obtain
valu
averag
defin
time
point
illustr
fig
anim
euthan
medetomidin
mgkg
ketamin
mgkg
ip
gener
anesthesia
sampl
complet
histolog
examin
organ
see
immunohistochemistri
spinal
cord
intestin
situ
hybrid
ish
spinal
cord
intestin
flow
cytometri
spleen
revers
transcriptionquantit
polymeras
chain
reaction
rtqpcr
spinal
cord
spleen
taken
dpi
experi
dpi
experi
ii
respect
experi
iii
noninfecti
condit
sampl
histolog
organ
see
immunohistochemistri
intestin
flow
cytometri
spleen
taken
day
necropsi
spleen
tissu
anim
process
flow
cytometri
addit
part
spleen
spinal
cord
tissu
cervic
thorac
lumbar
segment
immedi
snap
frozen
molecular
analys
remain
spinal
cord
segment
spleen
tissu
well
thymu
mesenter
lymph
node
ln
liver
stomach
pancrea
trachea
esophagu
thyroid
gland
heart
lung
kidney
adren
gland
ovari
uteru
urinari
bladder
tongu
salivari
gland
hair
skin
eye
skelet
muscl
femur
sternum
small
intestin
two
cross
section
cecum
one
cross
section
colon
five
cross
section
fix
formalin
h
embed
paraffin
wax
histolog
boni
tissu
femur
sternum
decalcifi
disodiumethylenediaminetetraacet
prior
embed
paraffin
embed
tissu
spinal
cord
intestin
also
use
immunohistochemistri
situ
hybrid
serial
section
cut
affix
coat
glass
slide
superfrost
slide
menzel
co
braunschweig
germani
section
organ
stain
hematoxylin
eosin
h
e
examin
routin
light
microscopi
presenc
inflammatori
chang
two
examin
au
ab
blind
treatment
group
addit
inflammatori
respons
small
intestin
cecum
colon
score
use
fourpart
semiquantit
score
system
modifi
tamaki
et
al
includ
follow
paramet
sever
none
mild
moder
sever
infiltr
extent
inflamm
none
inflamm
restrict
mucosa
inflamm
mucosa
submucosa
transmur
inflamm
affect
layer
percentag
area
affect
extent
crypt
damag
none
basal
affect
basal
affect
crypt
lost
surfac
epithelium
present
crypt
surfac
epithelium
lost
score
four
paramet
ad
cross
section
score
final
score
calcul
averag
segment
leukomyel
grade
cervic
thorac
lumbar
spinal
cord
cross
section
use
twopart
semiquantit
score
system
leukomyel
score
includ
perivascular
infiltr
pvi
chang
scatter
pvi
two
three
layer
three
layer
pvi
hypercellular
cell
cell
cell
per
high
power
field
previous
describ
arithmet
averag
calcul
segment
paramet
final
score
determin
averag
score
three
segment
anim
ad
score
pvi
hypercellular
immunohistochemistri
ihc
perform
use
polyclon
rabbit
ab
dakocytom
hamburg
germani
detect
cell
rat
monoclon
ab
bd
bioscienc
heidelberg
germani
detect
b
cell
polyclon
rabbit
antitmevspecif
ab
detect
tmevag
rat
antiforkhead
box
specif
monoclon
ab
ebiosci
frankfurt
germani
detect
treg
addit
rat
monoclon
ab
abd
serotec
oxford
uk
polyclon
goat
ab
santa
cruz
biotechnolog
inc
heidelberg
germani
detect
macrophagesmicroglia
modulatori
macrophagesmicroglia
respect
use
spinal
cord
tissu
damag
axon
label
goat
antinonphosphoryl
neurofila
npnf
specif
monoclon
ab
biolegend
london
uk
amount
myelin
basic
protein
mbp
determin
use
polyclon
rabbit
antimbpspecif
ab
chemicon
intern
hofheim
taunu
germani
colon
phenotyp
chang
determin
use
antibodi
macrophag
colon
mucosa
quantifi
use
ioniz
calcium
bind
adaptor
molecul
specif
polyclon
ab
wako
pure
chemic
industri
richmond
usa
reaction
conduct
previous
describ
summar
tabl
evalu
tmev
absolut
number
immunoreact
cell
count
three
spinal
cord
segment
anim
mbpneg
white
matter
area
measur
manual
map
magnif
use
fluoresc
microscop
keyenc
mechelen
belgium
bzii
analyz
softwar
keyenc
mechelen
belgium
area
measur
function
determin
npnfposit
axon
total
number
white
matter
three
spinal
cord
segment
enumer
colon
treg
cell
b
cell
cell
macrophag
infiltr
lamina
propria
count
ten
randomli
chosen
high
power
field
magnif
number
averag
addit
tmevspecif
ihc
perform
section
intestin
infect
anim
rule
enter
infect
ish
detect
tmevspecif
rna
cross
section
intestin
perform
describ
previous
spinal
cord
tissu
tmevinfect
noninfect
anim
theiler
murin
encephalomyel
use
posit
neg
control
respect
summar
pcr
product
gener
tmevinfect
babi
hamster
kidney
cell
cultur
rtqpcr
use
tmevspecif
primer
pair
shown
tabl
afterward
pcr
product
clone
pcr
plasmid
vector
amplifi
cell
topo
ta
clone
kit
sequenc
invitrogen
karlsruh
germani
vitro
transcript
accomplish
digrnalabel
mix
roch
diagnost
mannheim
germani
accord
manufactur
protocol
formalinfix
paraffinembed
tissu
section
dewax
wash
diethylpyrocarbon
depc
treat
water
sigmaaldrich
chemi
taufkirchen
germani
endogen
peroxidas
activ
block
levamisol
proteolysi
proteinas
k
roch
diagnost
mannheim
germani
acetyl
prehybrid
hybrid
realiz
overnight
probe
concentr
ngml
detect
system
compos
antidigoxigeninantibodi
conjug
alkalin
phosphatas
roch
diagnost
mannheim
germani
phosphat
sigmaaldrich
chemi
taufkirchen
germani
nitroblu
tetrazolium
chlorid
sigmaaldrich
chemi
taufkirchen
germani
rna
isol
mg
snap
frozen
spinal
cord
spleen
tmevand
mockinfect
anim
use
pcr
tissu
homogen
kit
gmbh
gaut
germani
qiazol
tm
lysi
reagent
qiagen
gmbh
hilden
germani
rneasi
mini
kit
qiagen
gmbh
hilden
germani
accord
protocol
subsequ
equal
amount
rna
transcrib
cdna
omniscript
tm
rt
kit
qiagen
gmbh
hilden
germani
rnaseout
tm
recombin
ribonucleas
inhibitor
invitrogen
tm
gmbh
karlsruh
germani
random
primer
promega
gmbh
mannheim
germani
describ
previous
revers
transcriptionquantit
polymeras
chain
reaction
rtqpcr
perform
tmev
tumor
necrosi
factor
tnf
interferon
ifn
transform
growth
factor
tgf
mbp
three
refer
gene
glyceraldehyd
dehydrogenas
hypoxanthinguaninphosphoribosyltransferas
spinal
cord
spleen
tissu
use
multiplex
quantit
pcr
system
brilliant
iii
ultrafast
sybr
green
rtqpcr
master
mix
agil
technolog
deutschland
germani
primer
sequenc
determin
use
input
softwar
use
sequenc
taken
literatur
primer
sequenc
list
tabl
quantif
tenfold
serial
dilut
standard
rang
prepar
normal
factor
correct
experiment
variat
calcul
three
refer
gene
genorm
softwar
version
phenotyp
analysi
peripher
leukocyt
spleen
sampl
dissolv
singl
cell
suspens
phosphatebuff
salin
contain
bsa
gibco
darmstadt
germani
erythrocyt
lyse
ad
ammoniumchloridepotassium
lyse
buffer
gibco
darmstadt
germani
cell
number
determin
use
trypan
blue
solut
sigma
aldrich
chemi
gmbh
taufkirchen
germani
neubauer
improv
chamber
avoid
unspecif
bind
fc
receptor
preincub
ab
clone
bioxcel
west
libanon
usa
perform
dead
cell
stain
use
live
fixabl
dead
cell
stain
kit
invitrogen
tm
gmbh
karlsruh
germani
describ
manufactur
subsequ
clone
ebiosci
san
diego
usa
pacificblu
clone
biolegend
london
uk
clone
bd
bioscienc
heidelberg
germani
clone
ebiosci
san
diego
usa
fitc
clone
biolegend
london
uk
ab
apc
clone
biolegend
london
uk
ad
fluorochromeconjug
surfac
marker
stain
intracellular
stain
transcript
factor
stain
buffer
set
ebiosci
san
diego
usa
use
accord
protocol
sampl
acquir
lsrii
sorp
cytomet
bd
bioscienc
heidelberg
germani
analyz
use
flowjo
softwar
version
tree
star
ashland
usa
gate
strategi
see
fig
statist
analys
conduct
use
statist
analysi
softwar
sa
enterpris
guid
window
sa
institut
inc
cari
nc
usa
data
gener
sever
mice
group
analyz
use
kruskalw
test
relat
two
group
perform
use
multipl
wilcoxon
ranksum
test
result
consid
statist
signific
pvalu
geometr
mean
fluoresc
intens
gmfi
cell
determin
use
flowjo
softwar
version
tree
star
ashland
usa
box
whisker
plot
gener
graphpad
prism
graphpad
softwar
la
jolla
usa
display
median
minimum
maximum
valu
well
upper
lower
quartil
receptor
blockad
caus
clinic
deterior
without
influenc
motor
coordin
theiler
murin
encephalomyel
viru
infect
sjl
mice
clinic
examin
mice
includ
perform
test
score
clinic
paramet
perform
character
neurolog
system
sign
caus
tmevinfect
blockad
respect
experi
clinic
examin
acut
infect
mice
perform
dpi
intracerebr
tmevinfect
induc
ataxia
motor
coordin
deficit
determin
rotarod
perform
test
dpi
mice
without
blockad
fig
howev
differ
detect
two
group
group
earli
tmev
group
isotyp
earli
tmev
dpi
fig
tabl
file
suggest
minor
absent
effect
blockad
upon
motor
coordin
spinal
cord
patholog
respect
expect
motor
coordin
deficit
observ
noninfect
mice
follow
blockad
group
mock
investig
time
point
fig
tabl
b
file
fatal
observ
treatment
group
clinic
score
reveal
ab
treatment
group
earli
tmev
earli
mock
earli
infect
phase
caus
increas
clinic
score
dpi
compar
anim
receiv
isotyp
control
ab
group
isotyp
earli
tmev
fig
tabl
b
file
affect
anim
display
reduc
activ
hunch
back
scurfi
hair
suggest
system
clinic
sign
noteworthi
unform
fece
ascrib
enter
diseas
observ
abtreat
mice
strikingli
clinic
score
dpi
significantli
increas
tmevinfect
mice
group
earli
tmev
compar
mockinfect
anim
group
earli
mock
follow
ab
treatment
suggest
trigger
addit
effect
acut
viru
infect
upon
deficiencymedi
system
sign
fig
tabl
b
file
dpi
increas
clinic
score
observ
infect
mice
group
earli
tmev
infect
mice
receiv
isotyp
control
ab
group
isotyp
earli
tmev
show
system
clinic
sign
primarili
consequ
viru
infect
later
time
point
obtain
data
experi
summar
tabl
ce
file
perform
test
earli
applic
receptor
block
antibodi
ab
dpi
arrow
reveal
motor
coordin
deficit
tmevinfect
anim
compar
mockinfect
mice
dpi
howev
differ
determin
aband
isotypetr
anim
white
box
tmevinfect
mice
without
ab
treatment
group
isotyp
earli
tmev
grey
box
tmevinfect
mice
treatment
group
earli
tmev
black
box
mockinfect
mice
treatment
group
earli
mock
b
experi
ii
applic
ab
dpi
arrow
caus
also
deterior
motor
coordin
start
dpi
howev
differ
observ
aband
isotypetr
anim
group
late
tmev
isotyp
late
tmev
white
box
tmevinfect
mice
without
ab
treatment
group
isotyp
late
tmev
grey
box
tmevinfect
mice
treatment
group
late
tmev
black
box
mockinfect
mice
treatment
group
late
mock
box
whisker
plot
display
median
minimum
maximum
valu
well
upper
lower
quartil
anim
use
investig
time
point
wilcoxon
ranksum
test
p
theiler
murin
encephalomyel
experi
ii
execut
determin
whether
trigger
effect
viru
infect
upon
deficiencymedi
sign
depend
upon
diseas
phase
rotarod
perform
test
perform
dpi
anim
ab
treatment
later
chronic
tme
phase
signific
declin
motor
coordin
found
dpi
mice
without
blockad
fig
tabl
f
file
group
late
tmev
isotyp
late
tmev
howev
differ
detect
group
late
tmev
group
isotyp
late
tmev
mice
fig
tabl
f
file
similar
experi
neurolog
defect
observ
noninfect
mice
follow
ab
treatment
group
late
mock
tabl
g
file
clinic
sore
reveal
significantli
increas
score
infect
mice
dpi
late
ab
applic
howev
differ
determin
group
group
late
tmev
isotyp
late
tmev
time
point
fig
tabl
f
file
show
chronic
viru
infect
limit
abil
trigger
deficiencymedi
effect
obtain
data
experi
ii
summar
tabl
ce
file
summari
result
show
neutral
caus
system
clinic
sign
sjl
mice
temporarili
dpi
enhanc
acut
tmevinfect
experi
convers
blockad
insuffici
alter
neurolog
deficit
motor
coordin
associ
tmevinduc
demyelin
diseas
differ
motor
coordin
observ
infect
mice
without
ab
treatment
experi
ii
receptor
blockad
lead
enhanc
recruit
cell
spinal
cord
demyelin
phase
theiler
murin
encephalomyel
influenc
viru
load
clinic
examin
reveal
neglig
effect
blockad
upon
cn
tmevinfect
mice
order
determin
subtl
chang
spinal
cord
tissu
evalu
histolog
ihc
rtqpcr
experi
ii
ab
treatment
late
infect
phase
lead
similar
clinic
score
tmevinfect
mice
without
blockad
anim
use
three
group
investig
time
point
wilcoxon
ranksum
test
arrow
administr
ab
isotyp
control
respect
red
asterisk
signific
differ
p
tmevinfect
mice
without
blockad
black
asterisk
signific
differ
p
block
mice
without
tmevinfect
green
asterisk
signific
differ
p
tmevinfect
mice
block
mice
previou
studi
sjl
mice
demonstr
occurr
progress
leukomyel
tmevinduc
demyelin
start
dpi
character
impact
blockad
acut
initi
tme
phase
ab
administ
onset
demyelin
spinal
cord
tissu
evalu
histolog
ihc
dpi
experi
histolog
score
reveal
signific
inflammatori
respons
dpi
mice
without
ab
treatment
fig
tabl
file
group
earli
tmev
isotyp
earli
tmev
howev
differ
observ
two
group
time
point
fig
noninfect
control
blockad
group
earli
mock
includ
dpi
show
spinal
cord
inflamm
fig
tabl
b
file
spinal
cord
inflamm
character
infiltr
cell
b
cell
treg
microgliamacrophag
microgliamacrophag
fig
accord
result
histolog
score
differ
found
group
earli
tmev
isotyp
earli
tmev
anim
tabl
file
addit
degre
spinal
cord
demyelin
determin
densiometr
analys
mbpunstain
area
fig
axon
damag
determin
npnfspecif
ihc
fig
found
tmevinfect
group
tabl
file
expect
spinal
cord
lesion
observ
histolog
immunohistochemistri
noninfect
mice
follow
ab
treatment
group
earli
mock
fig
fig
obtain
data
experi
summar
tabl
ce
file
rtqpcr
perform
initi
phase
virusinduc
leukomyel
dpi
lack
group
differ
confirm
show
similar
messeng
rna
mrna
express
level
select
cytokin
tnf
within
spinal
cord
group
earli
tmev
group
isotyp
earli
tmev
dpi
tabl
file
result
show
earli
system
blockad
unabl
significantli
influenc
cn
inflamm
tme
determin
impact
blockad
antivir
immun
amount
tmevag
rna
spinal
cord
measur
ihc
rtqpcr
match
find
differ
virusprotein
rna
level
observ
group
earli
tmev
group
isotyp
earli
tmev
anim
tabl
file
obtain
data
experi
summar
tabl
ce
file
sinc
tme
repres
biphas
diseas
directli
virusinduc
tissu
damag
acut
stage
immunopatholog
due
viru
persist
chronic
stage
ab
treatment
perform
also
later
time
point
experi
ii
anim
investig
histolog
ihc
chronic
demyelin
phase
dpi
although
differ
observ
regard
sever
leukomyel
determin
histolog
fig
sever
demyelin
axon
damag
determin
mbpand
npnfspecif
ihc
ihc
reveal
significantli
increas
number
cell
within
spinal
cord
dpi
day
onset
neutral
infect
mice
receiv
ab
group
late
tmev
fig
tabl
f
file
subsequ
spinal
cord
chang
dpi
evalu
molecular
level
show
mrna
transcript
significantli
decreas
block
mice
group
late
tmev
compar
isotypetr
anim
follow
tmevinfect
group
isotyp
late
tmev
fig
tabl
f
file
howev
mrna
express
tnf
remain
unchang
group
moreov
similar
mbpspecif
ihc
mbp
mrnaexpress
show
group
differ
tabl
f
file
result
indic
rather
mild
absent
effect
neutral
upon
spinal
cord
inflamm
patholog
obtain
data
experi
ii
summar
tabl
ce
file
similar
experi
neutral
late
tme
phase
influenc
viru
concentr
spinal
cord
dpi
determin
ihc
rtqpcr
tabl
f
file
collect
data
indic
system
blockad
unabl
alter
antivir
immun
acut
chronic
tme
experi
ii
howev
although
insuffici
influenc
sever
neurolog
sign
motor
coordin
demyelin
increas
cell
influx
togeth
reduc
transcript
spinal
cord
chronic
tme
clearli
demonstr
limit
gener
abil
system
neutral
alter
inflammatori
environ
within
cn
experi
ii
immunemedi
coliti
receptor
block
mice
aggrav
concurr
theiler
murin
encephalomyel
virusinfect
clinic
examin
reveal
acut
tmevinfect
caus
temporari
exacerb
system
clinic
sign
neutral
mice
order
determin
alter
induc
defici
inflamm
occur
mockinfect
anim
differ
observ
tmevinfect
anim
receiv
receptor
antibodi
ab
isotyp
control
arrow
indic
antibodi
treatment
dpi
earli
phase
tme
white
box
tmevinfect
mice
without
ab
treatment
group
isotyp
earli
tmev
grey
box
tmevinfect
mice
treatment
group
earli
tmev
black
box
mockinfect
mice
treatment
group
earli
mock
b
experi
ii
chronic
phase
applic
ab
dpi
arrow
caus
differ
tmevinfect
anim
receiv
ab
isotyp
control
white
box
tmevinfect
mice
without
ab
treatment
group
isotyp
late
tmev
grey
box
tmevinfect
mice
treatment
group
late
tmev
black
box
mockinfect
mice
treatment
group
late
mock
box
whisker
plot
display
median
minimum
maximum
valu
well
upper
lower
quartil
anim
use
investig
time
point
wilcoxon
ranksum
test
p
theiler
murin
encephalomyel
histolog
examin
mice
without
blockad
perform
sinc
abmedi
patholog
chang
larg
restrict
intestin
see
experi
iii
degre
coliti
quantifi
mice
blockad
acut
experi
chronic
experi
ii
tme
phase
experi
histolog
perform
dpi
tmevinfect
mice
without
earli
ab
treatment
comparison
group
earli
tmev
vs
isotyp
earli
tmev
coliti
observ
abtreat
mice
group
earli
tmev
signific
differ
compar
isotyp
treat
mice
group
isotyp
earli
tmev
present
dpi
tabl
file
test
hypothesi
cn
infect
exhibit
trigger
effect
upon
system
immunopatholog
block
sjl
mice
mockor
tmevinfect
histolog
examin
dpi
comparison
group
earli
tmev
vs
group
earli
notabl
simultan
infect
mice
treat
ab
earli
tme
phase
group
earli
tmev
result
transient
worsen
colon
diseas
compar
mockinfect
mice
group
earli
mock
dpi
fig
tabl
b
file
character
extens
leukocyt
infiltr
hyperplasia
crypt
epithelium
increas
crypt
damag
multifoc
transmur
inflamm
obtain
data
experi
summar
tabl
ce
file
tmevspecif
ihc
ish
perform
dpi
detect
possibl
direct
viral
effect
intestin
tract
result
reveal
viral
ag
rna
small
intestin
colon
caecum
investig
time
point
tmevinfect
mice
without
ab
treatment
group
isotyp
earli
tmev
earli
tmev
experi
ii
histolog
colon
perform
dpi
tmevinfect
mice
without
late
ab
treatment
comparison
group
late
tmev
simultan
mrna
express
significantli
decreas
tmevinfect
anim
follow
blockad
white
box
tmevinfect
mice
without
ab
treatment
group
isotyp
late
tmev
grey
box
tmevinfect
mice
treatment
group
late
tmev
black
box
mockinfect
mice
treatment
group
late
mock
box
whisker
plot
display
median
minimum
maximum
valu
well
upper
lower
quartil
anim
use
group
wilcoxon
ranksum
test
p
theiler
murin
encephalomyel
group
isotyp
late
tmev
reveal
significantli
increas
score
block
mice
dpi
tabl
f
file
howev
contrast
experi
blockad
later
time
point
induc
group
differ
day
ab
treatment
onset
dpi
tabl
f
file
expect
anim
receiv
isotyp
control
ab
group
isotyp
late
tmev
show
sign
coliti
tabl
g
file
obtain
data
experi
ii
summar
tabl
ce
file
similar
experi
tmevag
rna
detect
intestin
tract
ihc
ish
dpi
tmevinfect
mice
without
ab
treatment
group
isotyp
late
tmev
late
tmev
fig
result
show
acut
tmevinduc
neuroinflamm
abil
deterior
immunemedi
coliti
neutral
sjl
mice
experi
theiler
murin
encephalomyel
enhanc
peripher
cytokin
express
phenotyp
chang
receptor
block
sjl
mice
character
chang
peripher
immun
system
associ
deficiencymedi
coliti
phenotyp
cytokin
express
analys
spleen
tissu
perform
acut
experi
chronic
experi
ii
phase
tme
experi
flow
cytometri
rtqpcr
perform
dpi
mice
without
blockad
acut
tme
comparison
earli
tmev
vs
isotyp
earli
tmev
result
reveal
increas
express
cell
dpi
increas
frequenc
b
cell
togeth
reduc
rel
number
treg
enhanc
express
cell
dpi
group
earli
tmev
compar
group
isotyp
earli
tmev
indic
increas
cellular
significantli
elev
spleen
weight
found
block
mice
viru
infect
compar
isotyp
treat
mice
viru
infect
dpi
tabl
file
phenotyp
chang
associ
increas
transcript
dpi
dpi
dpi
dpi
indic
peripher
immun
enhanc
follow
neutral
tabl
file
obtain
data
experi
summar
tabl
ce
file
identifi
virusmedi
trigger
effect
upon
peripher
immun
system
associ
exacerb
immun
mediat
coliti
dpi
increas
clinic
score
dpi
phenotyp
chang
dpi
cytokin
express
dpi
spleen
compar
infect
noninfect
mice
follow
neutral
comparison
group
earli
tmev
vs
group
earli
mock
result
reveal
increas
percentag
b
cell
fig
decreas
percentag
cell
fig
within
spleen
follow
ab
treatment
earli
tme
phase
group
earli
tmev
dpi
togeth
upregul
mrna
express
tabl
b
file
rel
number
treg
elev
fig
anim
receiv
ab
tmev
group
earli
tmev
compar
control
anim
group
earli
mock
repres
potenti
compensatori
mechan
inhibit
overwhelm
peripher
inflammatori
respons
tissu
damag
respect
spleen
weight
significantli
increas
block
mice
follow
tmevinfect
dpi
tabl
b
file
character
function
state
cell
express
activ
marker
investig
express
cell
ctl
significantli
enhanc
tmevinfect
anim
group
earli
tmev
compar
noninfect
anim
follow
cytokin
receptor
blockad
group
earli
mock
fig
tabl
b
file
earli
administr
block
ab
led
increas
transcript
investig
proinflammatori
cytokin
tnf
andprob
compensatori
manneralso
antiinflammatori
cytokin
tmevinfect
mice
group
earli
tmev
compar
noninfect
anim
group
earli
mock
dpi
fig
tabl
b
file
worth
mention
highest
cytokin
transcript
level
measur
group
earli
tmev
anim
primarili
dpi
associ
exacerb
coliti
significantli
higher
level
p
statist
tendenc
increas
level
p
tnf
p
observ
dpi
compar
dpi
data
shown
suggest
transient
cytokin
enhanc
obtain
data
experi
summar
tabl
ce
file
experi
ii
flow
cytometr
analys
perform
dpi
rtqpcr
perform
dpi
mice
ab
treatment
chronic
diseas
phase
reduc
percentag
cell
togeth
increas
mrna
express
observ
tmevinfect
mice
follow
blockad
dpi
tabl
f
file
comparison
group
late
tmev
group
late
mock
reveal
blockad
late
tme
phase
led
elev
percentag
ctl
fig
butin
contrast
experi
iinduc
differ
activ
statu
cell
infect
mice
group
late
tmev
compar
noninfect
mice
group
late
mock
tabl
g
file
indic
diseas
phasespecif
differ
analog
experi
splenic
cytokin
express
chronic
infect
mice
determin
day
onset
ab
treatment
dpi
except
neutral
later
time
point
significantli
increas
mrnaexpress
investig
proand
antiinflammatori
cytokin
dpi
fig
tabl
f
file
infect
mice
obtain
data
experi
ii
list
tabl
ag
file
summari
result
confirm
abil
acut
cn
infect
caus
promin
cytokin
enhanc
neutral
sjl
mice
characterist
hyperact
immun
state
potenti
worsen
immun
mediat
coliti
function
relev
shown
associ
cell
ctl
activ
express
togeth
increas
frequenc
memori
cell
acut
infect
mice
ab
treatment
experi
receptor
blockad
lead
develop
sever
immun
mediat
coliti
sjl
mice
character
effect
upon
peripher
organ
blockad
sjl
mice
noninfecti
steadyst
condit
anim
experi
iii
receiv
ab
group
isotyp
control
group
isotyp
without
addit
tmevinfect
treatment
success
induc
sever
lymphohistiocyt
neutrophil
coliti
loss
goblet
cell
crypt
hyperplasia
crypt
necrosi
start
day
fig
histolog
chang
intestin
anim
share
common
featur
ibd
lesion
knockout
mous
model
signific
differ
present
differ
time
point
show
progress
diseas
cours
fig
ihc
reveal
blockad
caus
earli
signific
increas
cell
treg
macrophag
lamina
propria
colon
day
fig
b
cell
delay
signific
infiltr
colon
mucosa
found
day
first
ab
treatment
fig
interestingli
intestin
lesion
restrict
colon
sinc
signific
differ
observ
treat
anim
group
control
group
isotyp
also
caecum
dpi
tabl
h
file
histolog
chang
small
intestin
found
time
point
addit
inflammatori
lesion
found
tissu
see
materi
method
includ
cn
expect
anim
receiv
isotyp
control
group
isotyp
develop
typhlocol
fig
addit
intestin
inflamm
associ
significantli
increas
spleen
weight
block
mice
group
compar
control
anim
group
isotyp
dpi
obtain
data
experi
iii
summar
tabl
j
file
result
confirm
abil
neutral
breakdown
gut
immun
homeostasi
induc
immunemedi
coliti
sjl
mice
resembl
ibd
receptor
blockad
sjl
mice
accompani
decreas
level
regulatori
cell
togeth
enhanc
express
cell
spleen
order
investig
effect
upon
peripher
immun
respons
associ
blockad
phenotyp
chang
spleen
analyz
flow
cytometri
day
ab
treatment
splenocyt
sjl
mice
blockad
group
reveal
significantli
decreas
percentag
treg
compar
control
mice
group
isotyp
day
first
ab
applic
fig
notabl
rel
number
cell
cell
ctl
remain
unchang
indic
specif
downregul
treg
ab
treat
anim
simultan
gmfi
significantli
higher
cell
subset
block
mice
tnf
spleen
infect
mice
group
earli
tmev
compar
noninfect
anim
follow
antibodi
ab
treatment
group
earli
mock
j
flow
cytometri
reveal
rel
increas
b
cell
simultan
decreas
cell
k
spleen
infect
mice
follow
blockad
dpi
l
addit
rel
number
treg
spleen
increas
follow
tmevinfect
blockad
moreov
gmfi
n
gate
cell
gmfi
p
gate
cell
increas
dpi
infect
mice
follow
ab
treatment
gate
strategi
see
fig
ab
treat
anim
without
tmevinfect
group
earli
mock
ab
treat
mice
addit
tmevinfect
group
earli
tmev
box
whisker
plot
display
median
minimum
maximum
valu
well
upper
lower
quartil
anim
use
group
investig
time
point
wilcoxon
ranksum
test
p
theiler
murin
encephalomyel
group
gmfi
indic
memori
cell
differenti
elev
ctl
anim
group
compar
control
mice
group
isotyp
fig
tabl
h
file
obtain
data
experi
iii
summar
tabl
j
file
find
diminish
treg
respons
togeth
enhanc
activ
differenti
cell
within
spleen
support
assumpt
blockad
disturb
peripher
immun
toler
foster
system
immunopatholog
exhibit
profound
suppress
properti
thu
critic
control
physiolog
balanc
host
immun
respons
besid
immunemedi
coliti
induc
dysregul
signal
studi
illustr
complex
interplay
neuroinflamm
peripher
immun
respons
infecti
disord
abil
cnsrestrict
viru
infect
aggrav
system
immunopatholog
via
hyperact
immun
state
shown
repres
yet
undescrib
phenomenon
pleiotrop
cytokin
suppress
respons
reduc
antigenpres
cell
function
enhanc
respons
treg
expans
b
cell
matur
ab
product
genet
ablat
lead
spontan
coliti
mice
repres
reliabl
model
human
ibd
likewis
present
survey
show
neutral
induc
earli
onset
sever
enter
diseas
sjl
mice
similar
find
observ
earlyonsetibd
pediatr
disord
caus
genet
defect
affect
genomewid
associ
studi
also
reveal
central
role
axi
adult
ibd
pathogenesi
furthermor
autoantibodi
found
subset
human
ibd
patient
howev
pathogen
relev
remain
determin
disturb
mucos
homeostasi
mous
model
accompani
loss
intestin
regulatori
myeloid
cell
cx
high
treg
lead
aberr
respons
toward
commens
gut
microbiota
dietari
ag
noteworthi
genet
deficit
lead
proinflammatori
phenotyp
regulatori
cx
high
macrophag
develop
coliti
mice
present
studi
also
reduc
number
treg
togeth
increas
number
ctl
spleen
indic
unbalanc
immun
respons
may
contribut
progress
intestin
inflamm
ihc
reveal
initi
infiltr
predomin
cell
macrophag
delay
b
cell
infiltr
colon
neutral
mice
suggest
cellmedi
immunopatholog
domin
cellular
immun
respons
observ
also
crohn
diseas
humor
respons
suppos
account
ulcer
coliti
similar
human
ibd
seemingli
paradox
increas
mucos
infiltr
cell
associ
coliti
block
mice
sinc
treg
critic
prevent
intestin
inflamm
mucos
cell
unabl
control
gut
immun
homeostasi
present
studi
either
insuffici
amount
cellular
dysfunct
describ
immun
mediat
coliti
human
patient
recruit
sequestr
cell
colon
might
contribut
reduc
frequenc
splenic
treg
neutral
mice
observ
flow
cytometri
suscept
develop
intestin
inflamm
model
experiment
coliti
differ
among
inbr
mous
strain
previous
establish
induc
ibd
model
mice
infect
pathobiont
helicobact
hepaticu
anim
lack
bacteria
respond
abmedi
neutral
coliti
develop
use
sjl
anim
group
isotyp
white
box
vertic
line
block
anim
group
box
whisker
plot
display
median
minimum
maximum
valu
well
upper
lower
quartil
anim
use
investig
time
point
wilcoxon
ranksum
test
p
theiler
murin
encephalomyel
mice
prone
develop
disord
abl
induc
similar
intestin
lesion
without
addit
bacteri
trigger
predomin
detriment
respons
sjl
mice
signal
defect
also
exemplifi
therapeut
effect
abmedi
blockad
observ
wnvinfect
mice
lcmvinfect
balbc
mice
strikingli
acut
tmevinfect
capac
transient
exacerb
enter
diseas
block
mice
lack
detect
influenc
chronic
tme
upon
enter
sever
indic
diseas
phasespecif
effect
present
data
show
cn
infect
caus
theiler
murin
encephalomyel
system
hyperact
immun
state
follow
blockad
upregul
proand
antiinflammatori
cytokin
although
proof
causal
often
miss
infect
suppos
trigger
autoimmun
disord
ms
type
diabet
syndrom
system
lupu
erythematosu
molecular
mimicri
epitop
spread
releas
cryptic
ag
bystand
activ
respect
similarli
particip
virus
eg
measl
viru
mump
viru
cytomegaloviru
epsteinbarr
viru
initi
exacerb
ibd
human
patient
current
discuss
data
provid
evid
extraintestin
infect
enhanc
enter
diseas
recent
similar
effect
describ
experiment
respiratori
influenza
viru
infect
intestin
injuri
caus
lungderiv
virusspecif
effector
cell
destroy
intestin
homeostasi
promot
cell
polar
moreov
onset
eae
intestin
barrier
dysfunct
togeth
disturb
peripher
immun
homeostasi
probabl
caus
circul
myelinspecif
encephalitogen
cell
describ
thu
exacerb
coliti
follow
tmevinfect
might
caus
unspecif
bystand
stimul
colitogen
cell
direct
differ
dietari
antigen
andor
gut
microbiota
due
activ
peripher
immun
respons
explan
includ
molecular
mimicri
releas
cn
antigen
intestin
antigen
subsequ
crossreact
autoimmun
lymphocyt
discuss
associ
comorbid
ms
ibd
addit
stress
increas
intestin
permeabl
exacerb
enter
rat
suggest
braingut
interact
although
basic
mechan
remain
undetermin
also
correl
psycholog
disord
preval
cours
crohn
diseas
report
convers
intestin
barrier
damag
gut
microbiota
suppos
trigger
system
cn
autoimmun
might
contribut
observ
mild
increas
cell
infiltr
spinal
cord
chronic
tme
see
increas
intestin
permeabl
often
refer
leaki
gut
syndrom
also
observ
ms
system
autoimmun
diseas
type
diabet
interestingli
concurr
ibd
observ
subset
ms
patient
caus
comorbid
still
unclear
genet
factor
predispos
individu
develop
immun
mediat
disord
assum
acut
tme
phase
hyperact
immun
state
enhanc
cytokin
express
follow
neutral
accompani
elev
frequenc
activ
cell
increas
percentag
memori
cell
dpi
enhanc
cytotox
contribut
intestin
inflamm
murin
coliti
model
moreov
compar
present
find
increas
activ
memori
differenti
circul
ctl
associ
aggress
diseas
cours
includ
frequent
clinic
relaps
human
ibd
patient
furthermor
intestin
tract
damag
associ
system
cell
activ
use
dna
microarray
analys
previous
observ
activ
lymphoid
organ
cervic
ln
spleen
sjl
mice
earli
tme
dpi
follow
transcript
silenc
chronic
demyelin
phase
thu
transient
natur
peripher
immun
activ
tme
model
might
explain
observ
temporari
worsen
blockademedi
enter
acut
infect
diseas
phasedepend
alter
peripher
immun
respons
respect
increas
frequenc
foxp
treg
togeth
enhanc
mrna
express
modulatori
cytokin
might
repres
compensatori
attempt
sustain
peripher
immun
homeostasi
dampen
overwhelm
immun
respons
follow
neutral
concurr
acut
tmev
infect
expans
treg
shown
effici
reduc
antivir
immun
tmevinfect
sjl
mice
howev
probabl
due
limit
treg
recruit
cn
describ
immunohistochemistri
rtqpcr
treatment
effect
upon
viral
load
neuropatholog
found
present
studi
mild
increas
cell
influx
togeth
reduc
express
observ
infect
spinal
cord
follow
blockad
chronic
tme
phase
similarli
enhanc
tmevspecif
cell
respons
cn
associ
decreas
product
deplet
mice
ms
patient
leukocyt
disabl
produc
suppos
foster
cn
diseas
progress
inhibitori
effect
upon
neuroinflamm
also
illustr
blockad
eae
howev
contrast
eae
model
overt
chang
upon
spinal
cord
patholog
observ
tmevinfect
mice
follow
ab
treatment
present
experi
repres
pleotrop
cytokin
exhibit
detriment
neuroprotect
effect
differ
cn
disord
complex
probabl
ambival
function
also
observ
tme
model
instanc
treatment
recombin
reduc
spinal
cord
demyelin
suscept
mice
infect
daniel
strain
tmev
moreov
exogen
inhibit
tmev
replic
cultur
macrophag
contrast
studi
use
beantmev
strain
shown
excess
promot
pathogen
respons
viral
persist
prevent
apoptosi
virusinfect
cell
interplay
cytokin
also
contribut
cell
exhaust
inadequ
viral
elimin
tme
howev
sole
reduct
follow
neutral
appar
insuffici
alter
local
cn
inflammatori
respons
present
studi
addit
cn
viru
load
remain
unchang
indic
unaffect
antivir
immun
possibl
explan
limit
effect
treatment
tme
includ
autonom
immun
respons
trigger
viru
persist
spinal
cord
ii
inabl
ab
penetr
blood
spinal
cord
barrier
reach
suffici
cn
level
andor
iii
preferenti
recruit
inflammatori
cell
intestin
peripher
sequestr
tmevinfect
sjl
mice
local
ag
present
plasma
cell
differenti
spinal
cord
togeth
intact
blood
spinal
cord
barrier
suppos
caus
cnsrestrict
inflamm
similarli
closur
blood
brain
barrier
isol
cn
peripher
lymphoid
organ
suppos
play
pivot
role
therapi
failur
chronic
ms
patient
gener
cn
uptak
therapeut
antibodi
limit
intact
neurovascular
endothelium
thu
promin
blood
brain
barrier
damag
permeabl
present
experiment
wnvor
lcmvinfect
explain
restor
antivir
immun
cn
benefici
effect
treatment
infect
model
contrast
tme
detriment
effect
blockad
tme
might
circumv
adequ
ab
deliveri
system
across
blood
spinal
cord
barrier
guarante
suffici
cn
ab
level
reduc
system
advers
effect
summari
unlik
cn
infecti
model
pharmacolog
blockad
signal
tme
caus
sever
system
immunopatholog
mous
strain
suscept
genet
background
sinc
current
discuss
target
novel
therapeut
approach
chronic
viral
diseas
identif
critic
factor
regul
differ
organ
compart
crucial
understand
restor
protect
immun
especi
patient
genet
predisposit
develop
immun
mediat
disord
receptor
antibodi
ab
applic
earli
infect
phase
group
earli
mock
b
gate
splenocyt
anim
receiv
theiler
murin
encephalomyel
viru
tmev
infect
ab
group
earli
tmev
cell
first
gate
granular
size
singlet
follow
livedead
stain
exclus
death
cell
live
cell
test
surfac
express
viabl
express
subset
gate
express
gmfi
calcul
express
cell
separ
use
flowjo
softwar
tif
tabl
summari
statist
analys
experi
effect
blockad
acut
theiler
murin
encephalomyel
arrow
signific
downregul
tmevinfect
sjl
mice
receiv
ab
compar
mice
receiv
specif
isotyp
control
acut
phase
diseas
administr
ab
isotyp
control
respect
perform
dpi
bold
pvalu
signific
differ
group
p
determin
rank
sumtest
tmev
murin
encephalomyel
viru
dpi
day
post
infect
il
interleukin
tnf
tumor
necrosi
factor
tgf
transmiss
growth
factor
inf
interferon
forkhead
box
protein
mbp
myelin
basic
protein
npnf
nonphosphoryl
neurofila
gmfi
geometr
mean
fluoresc
intens
nd
determin
tabl
b
summari
statist
analys
experi
effect
acut
theiler
murin
encephalomyel
viru
infect
upon
blockad
arrow
signific
downregul
tmevinfect
sjl
mice
receiv
ab
compar
noninfect
mice
receiv
ab
acut
infect
phase
dpi
bold
pvalu
display
signific
differ
group
p
determin
rank
sumtest
tmev
murin
encephalomyel
viru
dpi
day
post
infect
il
interleukin
tnf
tumor
necrosi
factor
tgf
transmiss
growth
factor
inf
interferon
forkhead
box
protein
mbp
myelin
basic
protein
npnf
nonphosphoryl
neurofila
gmfi
geometr
mean
fluoresc
intens
nd
determin
tabl
c
summari
data
obtain
anim
receiv
tmevinfect
intraperiton
applic
antibodi
group
earlytmev
tabl
f
summari
statist
analys
experi
ii
effect
blockad
chronic
theiler
murin
encephalomyel
arrow
signific
downregul
tmevinfect
sjl
mice
receiv
ab
compar
mice
receiv
specif
isotyp
control
chronic
phase
diseas
administr
ab
isotyp
control
respect
perform
dpi
bold
pvalu
signific
differ
group
p
determin
rank
sumtest
tmev
murin
encephalomyel
viru
dpi
day
post
infect
il
interleukin
tnf
tumor
necrosi
factor
tgf
transmiss
growth
factor
inf
interferon
forkhead
box
protein
mbp
myelin
basic
protein
npnf
nonphosphoryl
neurofila
gmfi
geometr
mean
fluoresc
intens
nd
determin
tabl
g
summari
statist
analys
experi
ii
effect
chronic
theiler
murin
encephalomyel
viru
infect
upon
blockad
arrow
signific
upregul
downregul
infect
sjl
mice
receiv
ab
compar
noninfect
mice
receiv
ab
chronic
infect
phase
dpi
bold
pvalu
display
signific
differ
group
p
determin
rank
sumtest
tmev
murin
encephalomyel
viru
dpi
day
post
infect
forkhead
box
protein
mbp
myelin
basic
protein
npnf
nonphosphoryl
neurofila
gmfi
geometr
mean
fluoresc
intens
tabl
h
summari
statist
analys
experi
iii
effect
blockad
noninfect
anim
arrow
signific
downregul
sjl
mice
receiv
ab
compar
mice
receiv
specif
isotyp
administr
ab
isotyp
control
respect
perform
day
bold
pvalu
signific
differ
group
p
determin
rank
sumtest
ioniz
calcium
bind
adaptor
molecul
forkhead
box
protein
gmfi
geometr
mean
fluoresc
intens
tabl
summari
data
obtain
noninfect
anim
receiv
intraperiton
applic
ab
group
experi
iii
given
median
valu
minimum
maximum
gmfi
geometr
mean
fluoresc
intens
unit
point
semiquantit
score
number
label
cell
lamina
propria
per
high
power
field
percentag
label
cell
tabl
j
summari
data
obtain
noninfect
anim
receiv
intraperiton
applic
isotyp
control
group
isotyp
experi
iii
given
median
valu
minimum
maximum
gmfi
geometr
mean
fluoresc
intens
unit
point
semiquantit
score
number
label
cell
lamina
propria
per
high
power
field
percentag
label
cell
doc
